Literature DB >> 19811617

Silent subtype 3 carcinoma of the pituitary: a case report.

F Roncaroli, B W Scheithauer, E Horvath, D Erickson, C K Tam, R V Lloyd, K Kovacs.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19811617     DOI: 10.1111/j.1365-2990.2009.01043.x

Source DB:  PubMed          Journal:  Neuropathol Appl Neurobiol        ISSN: 0305-1846            Impact factor:   8.090


× No keyword cloud information.
  6 in total

Review 1.  Clinical review: Pituitary carcinoma: difficult diagnosis and treatment.

Authors:  Anthony P Heaney
Journal:  J Clin Endocrinol Metab       Date:  2011-09-28       Impact factor: 5.958

2.  Radiotherapy with concurrent temozolomide for the management of extraneural metastases in pituitary carcinoma.

Authors:  Carlos Kamiya-Matsuoka; David Cachia; Steven G Waguespack; Christopher H Crane; Anita Mahajan; Paul D Brown; Joo Yeon Nam; Ian E McCutcheon; Marta Penas-Prado
Journal:  Pituitary       Date:  2016-08       Impact factor: 4.107

Review 3.  Malignant transformation in non-functioning pituitary adenomas (pituitary carcinoma).

Authors:  Nèle Lenders; Ann McCormack
Journal:  Pituitary       Date:  2018-04       Impact factor: 4.107

4.  An Institutional Experience of Tumor Progression to Pituitary Carcinoma in a 15-Year Cohort of 1055 Consecutive Pituitary Neuroendocrine Tumors.

Authors:  Omalkhaire M Alshaikh; Sylvia L Asa; Ozgur Mete; Shereen Ezzat
Journal:  Endocr Pathol       Date:  2019-06       Impact factor: 3.943

5.  Pituitary carcinoma: A case report and discussion of potential value of combined use of Ga-68 DOTATATE and F-18 FDG PET/CT scan to better choose therapy.

Authors:  Heraldo Mendes Garmes; José Barreto Campello Carvalheira; Fabiano Reis; Luciano de Souza Queiroz; Mateus Dal Fabbro; Vanessa de Fatima Porto Souza; Allan de Oliviera Santos
Journal:  Surg Neurol Int       Date:  2017-08-01

Review 6.  Clinical and Pathological Aspects of Silent Pituitary Adenomas.

Authors:  Juliana Drummond; Federico Roncaroli; Ashley B Grossman; Márta Korbonits
Journal:  J Clin Endocrinol Metab       Date:  2019-07-01       Impact factor: 5.958

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.